Xuliang Shen
Impact in
-
- Carcinogens and Genotoxicity Assessment
-
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Glutathione Transferases and Polymorphisms 4
- DNA Repair Mechanisms 2
-
- Acute Myeloid Leukemia Research 5
- Hematopoietic Stem Cell Transplantation 2
- Co-authors
- Xiao‐Feng He (6 shared papers)Su-Lan Wang (3 shared papers)Zhizhong Liu (3 shared papers)Xianbin Yang (2 shared papers)Zhiping Jiang (2 shared papers)Yijian Chen (2 shared papers)Guangping Wang (1 shared paper)Liqun Zhang (1 shared paper)
- Journals
- Blood (2 papers)Gene (2 papers)Frontiers in Genetics (1 paper)Thrombosis and Haemostasis (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xuliang Shen
21 papers receiving 179 citations
Peers
Comparison fields: 5 of 51
- Cancer Research 30
- Pharmacology 17
- Molecular Biology 94
- Internal Medicine 4
- Oncology 29
Countries citing papers authored by Xuliang Shen
This map shows the geographic impact of Xuliang Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuliang Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuliang Shen more than expected).
Fields of papers citing papers by Xuliang Shen
This network shows the impact of papers produced by Xuliang Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuliang Shen. The network helps show where Xuliang Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuliang Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 31 | |
| 2 | 2014 | 29 | |
| 3 | 2013 | 24 | |
| 4 | 2008 | 23 | |
| 5 | 2014 | 19 | |
| 6 | 2014 | 18 | |
| 7 | 2010 | 10 | |
| 8 | 2023 | 4 | |
| 9 | 2020 | 3 | |
| 10 | 2014 | 3 | |
| 11 | 2022 | 2 | |
| 12 | 2015 | 2 | |
| 13 | Hematopoietic stem cell microtransplantation in patients aged over 70 with acute myeloid leukemia: a multicenter study. | 2023 | 2 |
| 14 | [Effect of brucine on secretion function and proliferation capability of T lymphocytes in patients with aplastic anemia]. | 2011 | 2 |
| 15 | 2024 | 1 | |
| 16 | 2015 | 1 | |
| 17 | 2017 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2015 | 1 | |
| 20 | [Apoptosis-inducing effects of brucine on human chronic myeloid leukemia cell line K562]. | 2011 | 1 |
About Xuliang Shen
Xuliang Shen is a scholar working on Molecular Biology, Hematology, Oncology, Pharmacology and Genetics, having authored 23 papers that have together received 179 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Glutathione Transferases and Polymorphisms (4 papers), Plant-based Medicinal Research (3 papers), DNA Repair Mechanisms (2 papers), BRCA gene mutations in cancer (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Cancer Research (30 citations), Pharmacology (17 citations), Molecular Biology (94 citations), Internal Medicine (4 citations) and Oncology (29 citations). Xuliang Shen has collaborated with scholars based in China and United States. Frequent co-authors include Xiao‐Feng He, Su-Lan Wang, Zhizhong Liu, Xianbin Yang, Zhiping Jiang, Yijian Chen, Guangping Wang, Liqun Zhang, Fang‐Ping Chen and Ben Lü. Their work appears in journals such as Blood, Gene, Frontiers in Genetics, Thrombosis and Haemostasis and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.